Outcomes of a Remote, Decentralized Health Center-Based HIV/AIDS Antiretroviral Program in Zambia, 2003 to 2007
- 1 January 2009
- journal article
- Published by SAGE Publications in Journal of the International Association of Physicians in AIDS Care
- Vol. 8 (1), 60-67
- https://doi.org/10.1177/1545109709331472
Abstract
A cross-sectional study of patients living with HIV/ AIDS treated during 2003 to 2007 in decentralized, rural health centers in Zambia was performed to measure virological outcomes after 12 months of antiretroviral therapy and identify factors associated with virological failure. Data from 228 patients who started antiretroviral therapy >12 months prior were analyzed. In all, 93% received stavudine + lamivudine + nevirapine regimens, and median antiretroviral therapy duration was 23.5 months (interquartile range 20-28). Of the 205 patients tested for viral load, 177 (86%) had viral load 1000 copies/mL) was 8.9% at 24 months and 19.6% at 32 months. Predictors for virological failure were 2, and women 12 months showed that positive health outcomes are achievable.Keywords
This publication has 13 references indexed in Scilit:
- Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans FrontièresAIDS, 2008
- Implementing Antiretroviral Therapy in Rural Communities: The Lusikisiki Model of Decentralized HIV/AIDS CareThe Journal of Infectious Diseases, 2007
- Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in ThailandInternational Journal of Infectious Diseases, 2007
- Reply to VogenthalerClinical Infectious Diseases, 2007
- Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of MalawiAIDS, 2006
- Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort studyAIDS, 2006
- Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessmentThe Lancet, 2006
- Is Moderate HIV Viremia Associated With a Higher Risk of Clinical Progression in HIV-Infected People Treated With Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Lessons Learned from Use of Highly Active Antiretroviral Therapy in AfricaClinical Infectious Diseases, 2005
- Efficacy of Antiretroviral Therapy Programs in Resource‐Poor Settings: A Meta‐analysis of the Published LiteratureClinical Infectious Diseases, 2005